["{\n\"step_by_step_thinking\": \"The relevant documents primarily discuss pharmacotherapy for relapsing-remitting multiple sclerosis. There is no direct evidence or mention of ocrelizumab or primary progressive multiple sclerosis. However, we can rule out options that are clearly not supported by the provided information. The documents do not suggest a specific treatment for primary progressive multiple sclerosis, so it's unlikely that ocrelizumab would be effective for this subtype.\",\n\"answer_choice\": \"B\""]